Company intelligence / Profile preview

Octomera

Germantown, Maryland, United Statesorgenesis.com ↗

Ownership: Private
Development stage: Other

Overview

Octomera operates a decentralized network of harmonized point-of-care centers (“POCare Centers”) that provide standardized, scalable manufacturing services for cell and gene therapies. The company’s proprietary OMPULs enable rapid deployment of GMP-compliant production processes across multiple sites. Octomera’s model aims to reduce the cost, complexity, and time required to develop and commercialize advanced therapies by shifting from centralized to decentralized manufacturing. The company also supports internal R&D programs in oncology with demonstrated proof-of-concept data.

Therapeutic areas: Oncology
Modalities: Cell therapyGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Academic instituteshospitalsindustry partners via the POCare NetworkPrivate equity investment from Metalmark Capital Partners/MM OS Holdings L.P.

Beyond the preview

Go deeper on Octomera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octomera.